Tuesday, February 9, 2010, 11:54pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Palatin Technologies Inc. (PTN)

 At 16:00 EST: 0.27 USD  Up 0.02 (7.53%)  
MORE ON PTN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
PALATIN TECH INC (AMEX:PTN) Delayed quote dataEdit
Last Trade: 0.27 USD
Trade Time: 4:00PM EST
Change: Up 0.02 (7.53%)
Prev Close: 0.25
Open: 0.25
Bid: N/A
Ask: N/A
1y Target Est: 0.50
Day's Range: 0.25 - 0.27
52wk Range: 0.06 - 0.48
Volume: 188,598
Avg Vol (3m): 499,786
Market Cap: 25.97M
P/E (ttm): N/A
EPS (ttm): -0.25
Div & Yield: N/A (N/A%)
Palatin Technologies Inc. (PTN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add PTN to Portfolio   Download Data

HEADLINES
• Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
PRNewswire (Tue 8:00am)
• Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
PRNewswire (Tue, Dec 1)
• PALATIN TECHNOLOGIES INC Financials
EDGAR Online Financials (Thu, Nov 19)
• Palatin Technologies Earnings Call scheduled for 11:00 am ET today
CCBN (Mon, Nov 16)
• PALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, Nov 16)
• Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
PRNewswire (Mon, Nov 16)
• Q1 2010 Palatin Technologies Earnings Release - 07:30 am ET
CCBN (Mon, Nov 16)
• PALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
• Palatin Technologies, Inc. To Report Fiscal Year 2010 First Quarter Results; Teleconference and Webcast to be held on November 16, 2009
PRNewswire (Thu, Nov 12)
• PALATIN TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Tue, Sep 29)
More Headlines for PTN...
ANALYST
EPS Est (next year) (Jun-08) : N/A
EPS Est (in 2 years) (Jun-09) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Palatin Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of receptor-specific small molecule and peptide therapeutics, including melanocortin (MC)-based therapeutics in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices